Nick Hart

ProSpect Pharma, Inc. provides drug designing services. It develops and markets and uses advanced technologies and products for the Life Science industries, particularly those related to drug design, vaccine development and metabolic studies. The company was founded in 2004 and is headquartered in Baltimore, MD.

Hemcon Medical Technologies, Inc. develops, manufactures, and markets technologies to control bleeding and infection resulting from trauma or surgery. Its solutions include military, emergency and trauma, dental, hemodialysis center, sports medicine, EMS, Cardiac Cath, IR and electrophysiology, wound debridement, occupational healthcare, and wilderness medicine solutions. The company was founded by William Wiesmann, Kenton Gregory, and Simon McCarthy in 2001 and is headquartered in Portland, OR.

Neuro3d SA develops pharmaceutical products to treat the central nervous system. Neuro3d has a full pipeline of innovative compounds with new mechanisms of action that have the potential to overcome the limitations of current drug therapies. It leads compound, the atypical antipsychotic ocaperidone, is being investigated in two international double-blind Phase II trials for treatment of schizophrenia. The company was founded in November 2000 and is headquartered in Mulhouse, France.